Under the Radar, page-267

Hi redant, on reflection I find it hard to entirely blame the failure of TGA approval on the current plight of the company.

It beggars belief that all Admedus ‘eggs’ were in the one basket and that cash flow postive forecasts were entirely dependent on those  approvals, so much so that a second CR would have to be done so soon after the May CR, after failure for approvals to materialise.

You could arguably say that it appears to have been such a bad miscalculation that it is has wiped out 70% of the company’s market capital, ( May CR sp of 30 cents to 10 cents) and severely damaged market sentiment (what there is of it).

From reasonable expections of a take over North of 30 cents to selling 20% of the company at a heavily discounted price.

I sincerely hope the financial welfare of shareholders will be in a far stronger postion than as of now, would I back my Life on it, .... no I wouldn’t but with SB on board remote chance of going bust.